In one of their periodic quizzes to test clinician knowledge, Medscape reinterates that caffeine consumption is associated with a LOWER risk of development of Parkinson’s Disease.
A relationship between increased caffeine intake and lower risk for Parkinson’s disease has been repeatedly confirmed. A more recent study that specifically focused on the effects of caffeine in individuals with a mutation in the leucine-rich repeat kinase 2 (LRRK2) gene found that that group in particular may benefit from caffeine-related therapies.
Yes, caffeine as a “therapy.”
Further, coffee consumption benefits patients with chronic liver disease.
A systematic review found that patients with chronic liver disease who consume coffee have a decreased risk for progression to cirrhosis, a lower mortality rate, and a lower rate of hepatocellular carcinoma development.
A combination of acetylsalicylic acid (aspirin), acetaminophen, and caffeine is approved in the US as a safe and effective treatment…
View original post 118 more words